You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cediranib

Showing 1 - 25 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Canada, United Kingdom (cediranib)

Active, not recruiting
  • Solid Tumors
  • cediranib
  • Edmonton, Alberta, Canada
  • +4 more
Sep 20, 2022

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Sarcoma, Alveolar Soft Part Trial run by the NCI (AZD2171)

Active, not recruiting
Has Results
  • Sarcoma, Alveolar Soft Part
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 11, 2022

Ovarian Cancer Trial in United Kingdom (Olaparib, Cediranib, Paclitaxel)

Active, not recruiting
  • Ovarian Cancer
  • Belfast, County Antrim, United Kingdom
  • +13 more
Feb 22, 2022

Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)

Active, not recruiting
  • Carcinosarcoma
  • Endometrial Neoplasms
  • Northwood, Middlesex, United Kingdom
  • +14 more
Feb 10, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +14 more
  • Cediranib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 31, 2022

Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Small Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +24 more
  • 18F-Fluoromisonidazole
  • +4 more
  • La Jolla, California
  • +15 more
Jan 3, 2023

Ovarian Cancer Trial in Worldwide (Olaparib, Cediranib)

Recruiting
  • Ovarian Cancer
  • Sydney, New South Wales, Australia
  • +53 more
Sep 26, 2022

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland

Completed
Has Results
  • Refractory Differentiated Thyroid Gland Carcinoma
  • +4 more
  • Cediranib
  • +3 more
  • Duarte, California
  • +32 more
Jun 24, 2021

Ovarian Cancer Trial in Manchester (Olaparib, Cediranib, Platinum-based Chemotherapy)

Completed
  • Ovarian Cancer
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 4, 2022

Rectal Cancer Trial in Manchester (AZD6244, Cediranib (AZD2171))

Terminated
  • Rectal Cancer
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
Feb 11, 2021

Colorectal Cancer, Lung Cancer, Solid Tumor Trial in Ottawa, Toronto (capecitabine, carboplatin, cediranib maleate)

Completed
  • Colorectal Cancer
  • +2 more
  • Ottawa, Ontario, Canada
  • +1 more
Mar 14, 2022

Extensive Stage Lung Small Cell Carcinoma Trial in United States (Carboplatin, Cediranib, Cediranib Maleate)

Terminated
Has Results
  • Extensive Stage Lung Small Cell Carcinoma
  • Los Angeles, California
  • +23 more
Mar 22, 2021

Renal Cell Cancer Trial in Cambridge (Olaparib, Cediranib, Durvalumab)

Recruiting
  • Renal Cell Cancer
  • Cambridge, England, United Kingdom
    Addenbrooke's Hospital
May 21, 2021

Endometrial Cancer, Ovarian Cancer, Cervical Cancer Trial in Boston (temsirolimus, cediranib)

Completed
  • Endometrial Cancer
  • +4 more
  • Boston, Massachusetts
  • +2 more
Apr 20, 2021

Uveal Melanoma, Metastatic Cancer Trial in Spain (Cediranib Maleate, Durvalumab)

Withdrawn
  • Uveal Melanoma
  • Metastatic Cancer
  • L'Hospitalet De Llobregat, Barcelona, Spain
  • +4 more
May 29, 2020

Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or

Completed
  • Unspecified Adult Solid Tumor, Protocol Specific
  • laboratory biomarker analysis
  • Calgary, Alberta, Canada
  • +3 more
Jan 25, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +14 more
  • Cediranib
  • +9 more
  • Birmingham, Alabama
  • +399 more
Dec 30, 2022

Lung Cancer Trial in Brazil, Canada (carboplatin, cediranib maleate, paclitaxel)

Completed
Has Results
  • Lung Cancer
  • Rio de Janeiro, Brazil
  • +18 more
Sep 16, 2020

Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in United

Recruiting
  • Endometrial Undifferentiated Carcinoma
  • +6 more
  • Birmingham, Alabama
  • +741 more
Feb 2, 2023

Platinum-resistant Recurrent Ovarian Cancer Trial in Seoul (olaparib+cediranib combination therapy, durvalumab + olaparib

Recruiting
  • Platinum-resistant Recurrent Ovarian Cancer
  • olaparib+cediranib combination therapy
  • +5 more
  • Seoul, Korea, Republic of
  • +2 more
Mar 29, 2021

Fallopian Tube Mucinous Adenocarcinoma, Ovarian Seromucinous Carcinoma, Platinum-Refractory Fallopian Tube Carcinoma Trial in

Recruiting
  • Fallopian Tube Mucinous Adenocarcinoma
  • +49 more
  • Cediranib Maleate
  • +5 more
  • Anchorage, Alaska
  • +373 more
Aug 17, 2022

Rectal Cancer Trial in Switzerland (drug, radiation, procedure)

Terminated
  • Rectal Cancer
  • Basel, Switzerland
  • +6 more
Jan 14, 2022

Refractory or Recurrent Solid Tumors, Acute Myelogenous Leukemia Trial in Philadelphia (Cediranib, AZD2171, RECENTIN)

Completed
  • Refractory or Recurrent Solid Tumors
  • Acute Myelogenous Leukemia
  • Cediranib, AZD2171, RECENTIN
  • Philadelphia, Pennsylvania
    Childrens Hospital, Philadelphia
Nov 20, 2019